Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART GIVES: Terconazole/metronidazole gel for vaginal infections
NCT02308007Phase 3Completed
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of terconazole, metronidazole in bacterial vaginosis (BV), vulvovaginal candidiasis (VVC). Started Jun 2015; status: completed.
02
Drugs
terconazolemetronidazole
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02308007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308007.